CASE REPORT
Aseptic Meningitis after BNT-162b2 COVID-19 Vaccination: Case Report and Literature Review
2023 年 72 巻 4 号 p. 102-105
詳細
2023 年 72 巻 4 号 p. 102-105
We encountered a-27-year-old female patient who developed refractory severe headache and photophobia after the first dose of COVID-19 vaccine. Despite her prior history of migraine, we diagnosed COVID-19 vaccine-induced aseptic meningitis. Symptoms were significantly resolved after methylprednisolone therapy. On reviewing the literature, we could find only nine similar cases, with over half of them affecting women aged 20–40 years. Although uncommon, aseptic meningitis should be suspected in patients with persistent or delayed onset of headache following COVID-19 vaccination.
